SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001585364-24-000070
Filing Date
2024-05-07
Accepted
2024-05-07 10:16:03
Documents
97
Period of Report
2024-03-30

Document Format Files

Seq Description Document Type Size
1 10-Q prgo-20240330.htm   iXBRL 10-Q 1558484
2 EX-22 cy24q110qex22.htm EX-22 58914
3 EX-31.1 cy24q110qex311.htm EX-31.1 9587
4 EX-31.2 cy24q110qex312.htm EX-31.2 9534
5 EX-32 cy24q110qex32.htm EX-32 9114
  Complete submission text file 0001585364-24-000070.txt   10040341

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20240330.xsd EX-101.SCH 69985
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20240330_cal.xml EX-101.CAL 110061
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20240330_def.xml EX-101.DEF 329336
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20240330_lab.xml EX-101.LAB 799554
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20240330_pre.xml EX-101.PRE 566938
101 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20240330_htm.xml XML 1861883
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36353 | Film No.: 24920171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)